BioMarin Pharmaceutical Inc. (BMRN) Stock News & Chart | StockAdder

(BMRN)

BioMarin Pharmaceutical Inc.

Stock chart and latest news for BioMarin Pharmaceutical Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

BioMarin Pharmaceutical Inc. News

PRO

Here Is Why BioMarin (BMRN) Is Projected to Rally

Apr 14, 2026 Yahoo Finance

BioMarin Pharmaceutical Inc. (BMRN) Rated Overweight at Wells Fargo Despite Voxzogo Phase 2 Study Discontinuations

Mar 30, 2026 Sahm

Is It Time To Reassess BioMarin Pharmaceutical (BMRN) After A 42.7% Three-Year Share Price Fall

Apr 10, 2026 PR Newswire

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

Oct 27, 2025 Stock Titan

BMRN SEC Filings - Biomarin Pharmaceutical Inc 10-K, 10-Q, 8-K Forms

Mar 27, 2026 The Globe and Mail

RBC Capital Sticks to Their Hold Rating for BioMarin Pharmaceutical (BMRN)

Apr 10, 2026 Yahoo Finance

Is BioMarin Pharmaceutical (BMRN) a Great Value Stock Right Now?

Jan 13, 2026 PR Newswire

BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results

Feb 23, 2026 Yahoo Finance

Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks

Mar 20, 2026 Yahoo Finance

Acquisition Plans to Fuel BioMarin Pharmaceutical (BMRN), According to Barclays

Feb 7, 2026 Yahoo Finance

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Sep 15, 2025 Yahoo Finance

BioMarin (BMRN) Down 13.6% Since Last Earnings Report: Can It Rebound?